NovaBay Pharma (NBY) Tops Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts NBY Hot Sheet
Price: $1.95 --0%
Financial Fact:
Operating income (loss): -2.01M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Operating income (loss): -2.01M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
NovaBay Pharma (NYSE: NBY) reported Q2 EPS of ($0.11), $0.01 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $4.1 million versus the consensus estimate of $4.25 million.
GUIDANCE:
NovaBay Pharma sees Q3 2017 revenue of $19 million.
For earnings history and earnings-related data on NovaBay Pharma (NBY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
- Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
